tiprankstipranks
OncoArendi Therapeutics SA (DE:1B1)
FRANKFURT:1B1
1B1
OncoArendi Therapeutics SA
RESEARCH TOOLSreports

Compare OncoArendi Therapeutics SA (1B1) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
1B1
OncoArendi Therapeutics SA
€1.21
€26.40M
-8.61
-37.92%
―
xxxxxxxxxxxxx
1B1
xxxxxxxxxxxxx
944
Biomaxima SA
€2.56
€11.28M
-49.14
-7.55%
―
xxxxxxxxxxxxx
1B1 vs 944
xxxxxxxxxxxxx
4VI
Genomtec SA
€0.96
€16.33M
-10.15
-39.83%
―
xxxxxxxxxxxxx
1B1 vs 4VI
xxxxxxxxxxxxx
9Y4
Ryvu Therapeutics SA
€6.35
€128.03M
-6.19
3.08%
―
xxxxxxxxxxxxx
1B1 vs 9Y4
xxxxxxxxxxxxx
60Q
Captor Therapeutics SA
€9.02
€105.51M
-4.87
158.27%
―
xxxxxxxxxxxxx
1B1 vs 60Q
xxxxxxxxxxxxx
272
Mabion SA
€1.85
€32.11M
-3.23
-8.10%
―
xxxxxxxxxxxxx
1B1 vs 272
xxxxxxxxxxxxx

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:1B1
OncoArendi Therapeutics SA
1.21
-0.67
-35.81%
DE:944
Biomaxima SA
2.27
-0.13
-5.62%
DE:4VI
Genomtec SA
0.96
-0.58
-37.40%
DE:9Y4
Ryvu Therapeutics SA
5.36
-0.32
-5.63%
DE:60Q
Captor Therapeutics SA
19.06
11.76
161.10%
DE:272
Mabion SA
1.96
-0.13
-6.35%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
Compare More Stocks >